The UK’s drug regulator, the MHRA, has taken a hit in terms of capacity and funding post-Brexit, and could benefit…
“if a suitable COVID-19 vaccine candidate, […] becomes available before the end of the transition period, EU legislation which we…
“Britain’s drug regulator is making 25% of its staff redundant amid financial pressures. The need for budget cuts is driven…